A randomized placebo-controlled, double-blind study to investigate the effect of a high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients, new insights on serum STAT-3 and hepassocin. - Concepedia

Concepedia

Publication | Closed Access

A randomized placebo-controlled, double-blind study to investigate the effect of a high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients, new insights on serum STAT-3 and hepassocin.

27

Citations

0

References

2023

Year

Sumaiah J. Alarfaj, Mostafa M. Bahaa, H A Yassin, Eman El‐Khateeb, Fedaa A. Kotkata, Mahmoud A. El-Gammal, AyaIbrahim Elberri, Eslam Habba, Esmat E Zien El-Deen, Mohannad O Khrieba,

Abstract

Cholecalciferol is recommended as additional therapy to modulate lipid peroxidation and systemic inflammation alongside other NAFLD therapies.